Selection of optimal dose of beta-blocker treatment in myocardial infarction patients based on changes in synchronization between 0.1 Hz oscillations in heart rate and peripheral microcirculation

Journal of Cardiovascular Medicine
Anton R KiselevBoris P Bezruchko

Abstract

Selection of the optimal dose of beta-blocker treatment in myocardial infarction (MI) patients is problematic because of a lack of well-established guidelines. We evaluated changes in synchronization between 0.1 Hz oscillations in heart rate (HR) and plethysmographic peripheral microcirculation in response to a tilt-table test and to 3-month treatment with the highest tolerated beta-blocker (metoprolol) dose in 43 patients aged between 41 and 77 years with acute MI 6 months prior to the start of the study. Before the study the patients were treated with small doses of beta-blocker. Phase differences between HR and peripheral microcirculation oscillations were used to measure the degree of synchronization (S), and relative change in S from horizontal position was used to characterize the response to vertical tilt. Two groups of MI patients matched for clinical characteristics were identified on the basis of the results. The first group was composed of patients with decreased S as a response to vertical tilt at the beginning of the study. The patients with increased S during vertical tilt before treatment with the highest tolerated beta-blocker dose were attributed to the second group. The response to vertical tilt in the first g...Continue Reading

References

Aug 1, 1991·Circulation·A MallianiS Cerutti
Jul 1, 1985·Clinical Pharmacology and Therapeutics·R BugiardiniS Lenzi
Sep 1, 1987·The American Journal of Physiology·R W deBoerJ Strackee
Dec 19, 2001·American Journal of Physiology. Heart and Circulatory Physiology·Simon C Malpas
Jun 7, 2002·Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·Mustafa RidhaRobert J Myerburg
Aug 3, 2002·The Journal of Physiology·Michael A Cohen, J Andrew Taylor
Jun 12, 2003·European Journal of Heart Failure·Anissa BouzamondoPhilippe Lechat
May 29, 2004·The American Journal of Cardiology·Olivia ManfriniRaffaele Bugiardini
Aug 4, 2004·European Heart Journal·José López-SendónUNKNOWN Task ForceOn Beta-Blockers of the European Society of Cardiology
Sep 3, 2004·European Heart Journal·Olivia ManfriniRaffaele Bugiardini
Jan 3, 2006·American Journal of Physiology. Heart and Circulatory Physiology·Olivia ManfriniRaffaele Bugiardini
Apr 19, 2007·European Heart Journal·Olivia Manfrini, Raffaele Bugiardini
Jun 16, 2007·European Heart Journal·Jean-Pierre BassandWilliam Wijns
Oct 24, 2007·European Heart Journal·Kristian ThygesenUNKNOWN Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
Jun 3, 2009·Current Vascular Pharmacology·Raffaele BugiardiniOlivia Manfrini
Jun 10, 2009·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Gabriel Tatu-ChitoiuRaffaele Bugiardini
Dec 17, 2009·Journal of Cardiovascular Medicine·Antonio Di MonacoFilippo Crea
Nov 11, 2010·Heart·Carmine Pizzi, Raffaele Bugiardini
Dec 7, 2010·Progress in Cardiovascular Diseases·Borejda Xhyheri, Raffaele Bugiardini
Jan 22, 2011·Journal of Cardiovascular Medicine·L Kristin Newby
Mar 9, 2011·European Heart Journal·Raffaele BugiardiniUNKNOWN Canadian Acute Coronary Syndrome Registry I and II Investigators
May 5, 2011·Journal of Cardiovascular Medicine·Regayip ZehirGonenc Kocabay

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Journal of Cardiovascular Medicine
Franck LaporteEtienne Aliot
Journal of Cardiovascular Medicine
Raghav GuptaGary T Kinasewitz
Journal of Cardiovascular Medicine
Francesco Fedele, Maria C Gatto
© 2022 Meta ULC. All rights reserved